Last Updated: July 14, 2026

ADEFOVIR Drug Patent Profile

Name: ADEFOVIR Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Adefovir, and when can generic versions of Adefovir launch?

Adefovir is a drug marketed by Apotex and Sigmapharm Labs Llc and is included in two NDAs.

The generic ingredient in ADEFOVIR is adefovir dipivoxil. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the adefovir dipivoxil profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Adefovir

A generic version of ADEFOVIR was approved as adefovir dipivoxil by SIGMAPHARM LABS LLC on August 29^th, 2013.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ADEFOVIR?
What are the global sales for ADEFOVIR?
What is Average Wholesale Price for ADEFOVIR?

Summary for ADEFOVIR

US Patents:	0
Applicants:	2
NDAs:	2
Drug Prices:	Drug price information for ADEFOVIR
DailyMed Link:	ADEFOVIR at DailyMed

Drug patent expirations by year for ADEFOVIR

US Patents and Regulatory Information for ADEFOVIR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex	ADEFOVIR DIPIVOXIL	adefovir dipivoxil	TABLET;ORAL	205459-001	Jul 6, 2018	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sigmapharm Labs Llc	ADEFOVIR DIPIVOXIL	adefovir dipivoxil	TABLET;ORAL	202051-001	Aug 29, 2013	AB	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.